Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/use-of-angiotensin-converting-enzyme-inhibitor-therapy-and-dose-n0GpR6lbYK
References (42)
-
M. Packer, P. Poole‐Wilson, P. Armstrong, J. Cleland, J. Horowitz, B. Massie, L. Rydén, K. Thygesen, B. Uretsky (1999)
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.Circulation, 100 23
-
(1998)
Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparisonEur Heart J, 19
-
Paula Rochon, Geoffrey Anderson, Jack Tu, J. Clark, J. Gurwitz, J. Szalai, P. Lau (1999)
Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 161 11
-
J. Nanas, George Alexopoulos, M. Anastasiou-Nana, Konstantinos Karidis, Argiris Tirologos, Spyridon Zobolos, Vlasios Pirgakis, Labros Anthopoulos, D. Sideris, S. Stamatelopoulos, Spyridon Moulopoulos (2000)
Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study. High Enalapril Dose Study Group.Journal of the American College of Cardiology, 36 7
-
H. Barron, S. Viskin, R. Lundstrom, B. Swain, A. Truman, C. Wong, J. Selby (1998)
Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization.Archives of internal medicine, 158 5
-
J. Tu, C. Pashos, C. Naylor, E. Chen, S. Normand, J. Newhouse, B. Mcneil (1997)
Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada.The New England journal of medicine, 336 21
-
M. Konstam, K. Dracup, David Baker, M. Bottorff, N. Brooks, R. Dacey, S. Dunbar, Anne Jackson, M. Jessup, Jerry Johnson, Robert Jones, R. Luchi, B. Massie, B. Pitt, E. Rose, Lewis Rubin, R. Wright, D. Hadorn (1995)
Heart failure: evaluation and care of patients with left ventricular systolic dysfunction.Journal of cardiac failure, 1 2
-
(1988)
Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failureJAMA, 259
-
PA Rochon, GM Anderson, JV Tu (1999)
Use of beta-blocker therapy in the elderly following acute myocardial infarctionCan Med Assoc J, 161
-
(1997)
Utilization and dosing of angiotensin-converting enyme inhibitors for heart failure: effect of physician specialty and patient characteristics -
BF Uretsky, JA Shaver, C Liang (1988)
Modulation of hemodynamic effects with a converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responsesAm Heart J, 116
-
P. Rochon, J. Tu, G. Anderson, J. Gurwitz, J. Clark, P. Lau, J. Szalai, K. Sykora, C. Naylor (2000)
Rate of heart failure and 1-year survival for older people receiving low-dose β-blocker therapy after myocardial infarctionThe Lancet, 356
-
Pallipamu Rao, D. Hosmer, S. Lemeshow (2000)
Applied Survival Analysis: Regression Modeling of Time to Event DataJournal of the American Statistical Association, 95
-
(1999)
Consensus recommendations for the management of heart failureAm J Cardiol, 83
-
H. Barron, S. Viskin, R. Lundstrom, B. Swain, A. Truman, Candice Wong, J. Selby (1998)
β-Blocker Dosages and Mortality After Myocardial Infarction: Data From a Large Health Maintenance OrganizationJAMA Internal Medicine, 158
-
H. Quan, Gerry Parsons, W. Ghali (2002)
Validity of Information on Comorbidity Derived From ICD-9-CCM Administrative DataMedical Care, 40
-
H. Krumholz, Yun Wang, Eugene Parent, Joyce Mockalis, M. Petrillo, M. Radford (1997)
Quality of care for elderly patients hospitalized with heart failure.Archives of internal medicine, 157 19
-
R. Deyo, D. Cherkin, D. Cherkin, M. Ciol (1992)
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.Journal of clinical epidemiology, 45 6
-
M Packer, PA Poole-Wilson, PW Armstrong (1999)
Comparative effects of low and high doses of the angiotensin-coverting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failureCirculation, 100
-
CD Naylor, P Slaughter (1999)
Cardiovascular Health and Services in Ontario -
P. Poole-Wilson, J. Cleland, W. Hubbard, G. Sutton, J. Pittard, C. Osborne, C. Long, S. Ingham, P. Robinson, S. Ball, J. Hampton, N. Poulter, G. Murray, C. Travill, R. Bain, A. Baksi, R. Baxter, A. Been, K. Berkin, R. Blackwood, R. Blandford, R. Boyle, M. Buchalter, R. Campbell, Challenor, B. Cheadle, A. Coats, P. Collins, C. Cowan, J. Creamer, C. Dancy, J. Davies, R. Davies, M. Ehsanulliah, A. Elder, Jm Fowler, R. Fulcher, M. Ghosh, R. Greenbaum, Tw Greenwood, S. Grimmer, J. Harvey, A. Heller, A. Henderson, T. Hendra, W. Hendrey, J. Hogan, K. Hollinrake, P. Holt, J. Hutton (1998)
Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison. The NETWORK Investigators.European heart journal, 19 3
-
Paula Rochon, Paul Fortin, Keith Dear, K. Minaker, Thomas Chalmers (1993)
Reporting of age data in clinical trials of arthritis. Deficiencies and solutions.Archives of internal medicine, 153 2
-
D. Forman, Ravi Cbander, K. Lapane, Parul Shah, J. Stoukides (1998)
Evaluating the Use of Angiotensin‐Converting Enzyme Inhibitors For Older Nursing Home Residents with Chronic Heart FailureJournal of the American Geriatrics Society, 46
-
J. Cohn, M. Hawkins, H. Levine, J. Naughton, E. Rapaport, S. Goldstein, B. Pitt, R. Cody, P. Deedwania, L. Dennick, J. Franciosa, M. McGovern, J. Meyer, A. Gradman, B. Massie, M. Packer, J. Doherty, J. Gammill, W. Cooper, S. Engel, R. Fand, Barbara Hallows, L. Kerwin, Debra Soltesz, J. Parker, K. Lahey, E. Carbajal, P. Watson, R. Dibianco, J. Ronan, D. Donohue, K. Lindgren, L. Larca, J. Freitag, Donna Lindemuth, J. Lakier, H. Rosman, M. Włodkowski, R. Cody, S. Kubo, M. Clark, K. Pondolfino, M. Wilén, Drexel Jordan, S. Das, J. Nicklas, Mary Foley, M. Higginbotham, F. Cobb, Jean Wilson, D. Berkson, D. Obradovic, P. Hershinow, N. Nicholls, H. Ikram, I. Crozier, C. Pepine, John Culp, M. Limacher, Kathy Mulvehill-Verbust, D. Farnham, Dorothy Adams, Norene Streicher, C. Shanley, M. Greenberg, J. Strain, M. Hewitt, Barbara Levine, D. Sharpe, R. Briant, R. Coxon, J. Cornyn, N. Topić, H. Willens, Denise Antonishen, D. Reinstein, H. Colfer, Karen Graham, G. Perlow, H. Zarren, B. Bent, Marjorie Zicherman, B. Zaret, Deborah Lawrason, Pat Tellier, Kathy O'Keefe, S. Mohiuddin, L. Stengel, J. Madison, N. Carruthers, F. Elijovich, M. O'Sullivan, U. Elkayam, S. Rahimtoola, L. Weber, S. Gottlieb, Carol Brown, M. Jessup, S. Ulrich, Jane Kronenthal, D. Capaccio, Colin Grant, E. Gillie, Pat Wood, F. Fouad-Tarazi, Kay Petey (1988)
Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group.JAMA, 259 4
-
(1987)
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).The New England journal of medicine, 316 23
-
M. Charlson, P. Pompei, Kathy Ales, C. MacKenzie (1987)
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.Journal of chronic diseases, 40 5
-
S. Yusuf, B. Pitt, C. Davis, W. Hood, J. Cohn (1991)
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.The New England journal of medicine, 325 5
-
(1999)
Cardiovascular Health and Services in Ontario. Toronto, Ontario: Institute for Clinical Evaluative Sciences -
(1995)
Guidelines for the evaluation and management of heart failureJ Am Coll Cardiol, 26
-
A. Hunt, David Baker, Marshall Chin, Michael Cinquegrani, A. Feldman, Gary Francis, Theodore Ganiats, Sidney Goldstein, G. Gregoratos, L. Jessup, R. Noble, Milton Packer, Marc Silver, L. Stevenson, R. Gibbons, Elliott Antman, Valentin Fuster, A. Jacobs, L. Hiratzka, Richard Russell, Sidney Smith (2002)
ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary -
John Williams, M. Bristow, M. Fowler, G. Francis, A. Garson, B. Gersh, D. Hammer, M. Hlatky, C. Leier, M. Packer, B. Pitt, D. Ullyot, L. Wexler, W. Winters, J. Ritchie, M. Cheitlin, K. Eagle, T. Gardner, R. Gibbons, Richard Lewis, R. O'rourke, T. Ryan (1995)
Guidelines for the Evaluation and Management of Heart Failure Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)Circulation, 92
-
P. Rochon, G. Anderson, J. Tu, J. Gurwitz, J. Clark, N. Shear, P. Lau (1999)
Age‐ and Gender‐Related Use of Low‐Dose Drug Therapy: The Need to Manufacture Low‐Dose Therapy and Evaluate the Minimum Effective DoseJournal of the American Geriatrics Society, 47
-
Al-Senawi Da, Naylor Cd, P. Austin, J. Tu (1999)
Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction.The New England journal of medicine, 341 18
-
Denis Clement, M. Buyzere, M. Tomas, Guy Vanavermaete (2000)
Long-term effects of clinical outcome with low and high dose in the Captopril in Heart Insufficient Patients Study (CHIPS)Acta Cardiologica, 55
-
Jack Tu, Edward Hannan, G. Anderson, Karey Iron, Keyi Wu, Karen Vranizan, A. Popp, K. Grumbach (1998)
The fall and rise of carotid endarterectomy in the United States and Canada.The New England journal of medicine, 339 20
-
Donald Rubin (1997)
Estimating Causal Effects from Large Data Sets Using Propensity ScoresAnnals of Internal Medicine, 127
-
R. Deyo, D. Cherkin, M. Ciol (1992)
ADAPTING A CLINICAL COMORBIDITY USE WITH ICD-g-CM ADMINISTRATIVE INDEX FOR DATABASES -
DW Hosmer, S Lemeshow (1999)
Applied Survival Analysis -
A Argesti (1990)
Categorical Data Analysis -
B. Uretsky, J. Shaver, C. Liang, D. Amin, P. Shah, T. Levine, P. Walinsky, T. LeJemtel, T. Linnemeier, J. Rush (1988)
Modulation of hemodynamic effects with a converting enzyme inhibitor: acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses.American heart journal, 116 2 Pt 1
-
JN Nanas, G Alexopoulos, MI Anastasiou-Nana (2000)
Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter studyJ Am Coll Cardiol, 36
-
(1998)
Compendium of pharmaceuticals and specialities
- Publisher
- Springer Journals
- Copyright
- Copyright © 2004 by Society of General Internal Medicine
- Subject
- Medicine & Public Health; Internal Medicine
- ISSN
- 0884-8734
- eISSN
- 1525-1497
- DOI
- 10.1111/j.1525-1497.2004.30328.x
- pmid
- 15209607
- Publisher site
- See Article on Publisher Site
Abstract
OBJECTIVE: To evaluate the dose-related benefit of angiotensin-converting enzyme (ACE) inhibitor therapy among older adults with heart failure and to evaluate whether low-dose ACE inhibitor therapy is better than none.
Journal
Journal of General Internal Medicine – Springer Journals
Published: May 30, 2004